StockData
Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc. (CRDF) stock

CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.85−0.04 (-4.46%)

Close on Nov 20, 2026Market cap $66.34MP/E –Yield –

Cardiff Oncology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cardiff Oncology's total debt was $234.27K at Jun 30, 2020. For fiscal 2019 it was $0. The highest annual figure on record is $16.54M in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0-100.0%
FY2017Dec 31, 2017$1.33M-91.9%
FY2016Dec 31, 2016$16.54M+0.4%
FY2015Dec 31, 2015$16.47M+10.2%
FY2014Dec 31, 2014$14.95M+2768.9%
FY2013Dec 31, 2013$521.16K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020$234.27K–
Q4 FY2019Dec 31, 2019$0-100.0%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$1.17M-92.9%
Q4 FY2017Dec 31, 2017$1.33M-91.9%
Q3 FY2017Sep 30, 2017$1.49M-94.0%
Q2 FY2017Jun 30, 2017$1.64M–
Q1 FY2017Mar 31, 2017$16.57M–
Q4 FY2016Dec 31, 2016$16.54M–
Q3 FY2016Sep 30, 2016$24.89M–

More Cardiff Oncology figures

See a number that looks wrong?